Table 2.
Numbers of participants with additional features, by age group and sex, and by feature–cancer combination
| Cancer and additional feature | Women, n (%) | Men, n (%) | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Aged 40–59 years (n= 29 920) | Aged 60–69 years (n = 14 955) | Aged ≥70 years (n= 23 008) | Aged 40–59 years (n= 29 944) | Aged 60–69 years (n = 14 506) | Aged ≥70 years (n= 13 460) | |
| Colorectal, ovary, oesophagogastric, liver | ||||||
| Abdominal mass | 67 (0.2) | 51 (0.3) | 85 (0.4) | 63 (0.2) | 32 (0.2) | 57 (0.4) |
|
| ||||||
| Colorectal, ovary | ||||||
| Change in bowel habit | 281 (0.9) | 201 (1.3) | 330 (1.4) | n/a | n/a | n/a |
|
| ||||||
| Colorectal, pancreas | ||||||
| Constipation | 810 (2.7) | 586 (3.9) | 1765 (7.7) | 645 (2.2) | 574 (4.0) | 1118 (8.3) |
| Diarrhoea | 988 (3.3) | 648 (4.3) | 1474 (6.4) | 1065 (3.6) | 578 (4.0) | 644 (4.8) |
|
| ||||||
| Pancreas, oesophagogastric | ||||||
| Nausea and/or vomiting | 833 (2.8) | 567 (3.8) | 1486 (6.5) | 626 (2.1) | 325 (2.2) | 587 (4.4) |
|
| ||||||
| Colorectal, oesophagogastric, pancreas, ovary | ||||||
| Weight loss | 108 (0.4) | 91 (0.6) | 316 (1.4) | 158 (0.5) | 116 (0.8) | 222 (1.6) |
|
| ||||||
| Bladder, kidney | ||||||
| Haematuria | 100 (0.3) | 88 (0.6) | 129 (0.6) | 182 (0.6) | 119 (0.8) | 199 (1.5) |
| Urinary tract infection | 1514 (5.1) | 1013 (6.8) | 2183 (9.5) | 352 (1.2) | 261 (1.8) | 506 (3.8) |
|
| ||||||
| Uterus, oesophagogastric | ||||||
| Low haemoglobin | 2145 (7.2) | 1209 (8.1) | 4069 (17.7) | n/a | n/a | n/a |
| Raised platelets | 1001 (3.3) | 636 (4.3) | 1348 (5.9) | n/a | n/a | n/a |
n/a = not applicable: included because people born of male sex cannot be diagnosed with uterine cancer or with ovarian cancer.